These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1059658)

  • 1. Feulgen microspectrophotometry of oral cancer and leukoplakia.
    Doyle JL; Manhold JH
    J Dent Res; 1975; 54(6):1196-9. PubMed ID: 1059658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microspectrophotometric determination of DNA in oral lesions.
    Giménez IB; Conti CJ
    J Oral Surg; 1977 Jun; 35(6):465-8. PubMed ID: 266061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content in reactive hyperplasia, precancerosis, and carcinomas of the oral cavity. A cytophotometric study.
    Doseva D; Christov K; Kristeva K
    Acta Histochem; 1984; 75(2):113-9. PubMed ID: 6441421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of oral precancerous lesions].
    Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
    Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA content as a prognostic marker in patients with oral leukoplakia.
    Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
    N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta 2 microglobulin in oral malignancy and premalignancy.
    Scully C
    J Oral Pathol; 1981 Oct; 10(5):354-7. PubMed ID: 6174717
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
    Jiang Y; Wu Y; Wang F
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Site-specific incidence of benign and precancerous leukoplakias and cancers of the oral cavity].
    Schell H; Schönberger A
    Z Hautkr; 1987 May; 62(10):798-804. PubMed ID: 3617851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of oral neoplasms--precancerous lesions (leukoplakia) and early neoplastic morphological changes].
    Chiba H
    Shiyo; 1981 Oct; (10):25-8. PubMed ID: 6947129
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytoplasmic receptors of steroid sex hormones in malignant tumors amd precancerous processes of the human oral mucosa].
    Bassalyk LS; Falileev GV; Kushlinskiĭ NE; Nagibin AA
    Vopr Onkol; 1987; 33(1):28-30. PubMed ID: 3811307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas.
    Vigneswaran N; Peters KP; Hornstein OP; Haneke E
    J Oral Pathol Med; 1989 Aug; 18(7):377-90. PubMed ID: 2479742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskeratosis in human and experimental oral precancer and cancer. An immunohistochemical and ultrastructural study in men, mice and rats.
    Löning T; Burkhardt A
    Arch Oral Biol; 1982; 27(5):361-6. PubMed ID: 6180717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-phase fraction and DNA ploidy in oral leukoplakia.
    Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
    ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Further laboratory studies on the completion of classification criterias for dysplasia in oral precancerous conditions].
    Fuchs G
    Stomatol DDR; 1985 Sep; 35(9):532-9. PubMed ID: 3914110
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukoplakia as a precancerous lesion of the oral cavity].
    Tana M; Cortellessa R; Giacomini G; Coletti C; Giacomini G
    Riv Ital Stomatol; 1984 Feb; 53(2):115-20. PubMed ID: 6591351
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical expression of DNA methyltransferases 1, 3a and 3b in oral leukoplakias and squamous cell carcinomas.
    Daniel FI; Rivero ER; Modolo F; Lopes TG; Salum FG
    Arch Oral Biol; 2010 Dec; 55(12):1024-30. PubMed ID: 20951977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
    Scheifele C; Schlechte H; Bethke G; Reichart PA
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.